Literature DB >> 31863244

Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet).

Federica Pulvirenti1, Maria Sangerardi2, Alessandro Plebani3, Annarosa Soresina3, Andrea Finocchi4, Claudio Pignata5, Emilia Cirillo5, Antonino Trizzino6, Alessandro Aiuti7, Maddalena Migliavacca7, Franco Locatelli8, Alice Bertaina8, Samuele Naviglio9, Maria Carrabba10, Marco De Carli11, Maria Grazia Foschino Barbaro12, Marco Gattorno13, Isabella Quinti1,14, Baldassarre Martire15.   

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections, inflammation, and autoimmunity with an impact on health-related quality of life (HRQoL). Few data are available for children, whereas no study has been conducted in adults. Here, we investigated HRQoL and emotional functioning of 19 children and 28 adults enrolled in Italian registry for CGD. PEDsQL and SDQ were used for children and their caregivers, and adults completed the SF-12 questionnaire. Mean scores were compared with norms and with patients affected by chronic diseases. Comparisons were made for CGD patients who underwent or not hematopoietic stem cell transplantation (HSCT). When compared with norms, CGD children exhibited higher difficulties in social/school areas, peer relationship, and conduct/emotional problems (< 5 years of age), as scored by proxies. Differently, CGD adults reported higher difficulties both in mental and physical area than norms. Only for children, clinical status had a damaging effect on psychosocial and school dimensions, whereas age had a negative impact on social areas. No significant difference was observed between patients treated or not with HSCT. When compared with patients affected by chronic diseases, CGD children and adults both displayed fewer physical disabilities. Differently, in mental scale adults scored lower than those with rheumatology diseases and had similar impairment in comparison with patients with diabetes mellitus and cancer. This study emphasized the impact of CGD on HRQoL since infancy and its decline in adulthood, with emotional difficulties occurring early. HRQoL impairment should be considered in clinical picture of CGD and pro-actively assessed and managed by clinicians.

Entities:  

Keywords:  Chronic granulomatous disease; PEDsQL; SDQ; SF-12; burden of disease; emotional difficulties; health-related quality of life; hematopoietic stem cell transplantation

Mesh:

Substances:

Year:  2019        PMID: 31863244     DOI: 10.1007/s10875-019-00725-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

2.  Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.

Authors:  Theresa Cole; Fiona McKendrick; Penny Titman; Andrew J Cant; Mark S Pearce; Catherine M Cale; David Goldblatt; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2012-08-12       Impact factor: 8.317

3.  Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-Analysis.

Authors:  Dmitrii Peshko; Ekaterina Kulbachinskaya; Ilya Korsunskiy; Elena Kondrikova; Federica Pulvirenti; Isabella Quinti; Oleg Blyuss; Audrey Dunn Galvin; Daniel Munblit
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-20

4.  The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.

Authors:  James W Varni; Tasha M Burwinkle; Ernest R Katz; Kathy Meeske; Paige Dickinson
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

5.  Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire.

Authors:  Isabella Quinti; Federica Pulvirenti; Patrizia Giannantoni; Joud Hajjar; Debra L Canter; Cinzia Milito; Damiano Abeni; Jordan S Orange; Stefano Tabolli
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-21

Review 6.  Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.

Authors:  Elena Soncini; Mary A Slatter; Laura B K R Jones; Stephen Hughes; Stephen Hodges; Terence J Flood; Dawn Barge; Gavin P Spickett; Graham H Jackson; Matthew P Collin; Mario Abinun; Andrew J Cant; Andrew R Gennery
Journal:  Br J Haematol       Date:  2009-02-16       Impact factor: 6.998

7.  Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.

Authors:  L B K R Jones; P McGrogan; T J Flood; A R Gennery; L Morton; A Thrasher; D Goldblatt; L Parker; A J Cant
Journal:  Clin Exp Immunol       Date:  2008-05       Impact factor: 4.330

8.  Itraconazole to prevent fungal infections in chronic granulomatous disease.

Authors:  John I Gallin; David W Alling; Harry L Malech; Robert Wesley; Deloris Koziol; Beatriz Marciano; Eli M Eisenstein; Maria L Turner; Ellen S DeCarlo; Judith M Starling; Steven M Holland
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

9.  Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.

Authors:  Caridad A Martinez; Sweta Shah; William T Shearer; Howard M Rosenblatt; Mary E Paul; Javier Chinen; Kathryn S Leung; Alana Kennedy-Nasser; Malcolm K Brenner; Helen E Heslop; Hao Liu; Meng-Fen Wu; Imelda C Hanson; Robert A Krance
Journal:  J Allergy Clin Immunol       Date:  2011-11-12       Impact factor: 10.793

10.  Who should measure quality of life, the doctor or the patient?

Authors:  M L Slevin; H Plant; D Lynch; J Drinkwater; W M Gregory
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

View more
  2 in total

1.  Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019.

Authors:  Wen-I Lee; Cheng-Hsun Chiu; Chao-Yi Wu; Yi-Ching Chen; Jing-Long Huang; Li-Chen Chen; Liang-Shiou Ou; Tsung-Chieh Yao; Tang-Her Jaing; Shih-Hsiang Chen; Chi-Jou Liang; Chen-Chen Kang
Journal:  J Clin Immunol       Date:  2021-05-08       Impact factor: 8.317

2.  Late diagnosis and advances in genetics of chronic granulomatous disease.

Authors:  G Di Matteo; A Finocchi
Journal:  Clin Exp Immunol       Date:  2020-12-13       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.